0001093557-22-000023.txt : 20220302
0001093557-22-000023.hdr.sgml : 20220302
20220302164223
ACCESSION NUMBER: 0001093557-22-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patterson Chad
CENTRAL INDEX KEY: 0001850152
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 22704358
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-03-01
0
0001093557
DEXCOM INC
DXCM
0001850152
Patterson Chad
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
EVP, Global Marketing
Common Stock
2022-03-01
4
S
0
46
413.97
D
12528
D
On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Included in this number are 12,528 unvested restricted stock units, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
By: Jereme Sylvain For: Chad M Patterson
2022-03-02